Characterization of the neurochemical and behavioral effects of solriamfetol (JZP-110), a selective dopamine and norepinephrine reuptake inhibitor

MG Baladi, MJ Forster, MB Gatch, RB Mailman… - … of Pharmacology and …, 2018 - ASPET
Excessive sleepiness (ES) is associated with several sleep disorders, including narcolepsy
and obstructive sleep apnea (OSA). A role for monoaminergic systems in treating these …

Multiple daytime administration of the selective orexin-2 receptor antagonist JNJ-42847922 induces somnolence in healthy subjects without residual central effects

PD van der Ark, G Golor, L van Nueten… - Journal of …, 2018 - journals.sagepub.com
Background: Pharmacokinetics, pharmacodynamics and general safety and tolerability of
JNJ-42847922, a selective orexin-2 receptor antagonist, were assessed in healthy subjects …

[HTML][HTML] 食欲素受体拮抗剂治疗失眠症研究进展

黎越丹, 崔冬晓, 孙彦, 贾艳艳, 王平安 - 药学学报, 2018 - html.rhhz.net
发现于1998 年的食欲素体系(orexin system), 包括两个G-蛋白偶联受体(G-protein coupled
receptors, GPCRs): 食欲素-1 受体(orexin-1 receptor, OX 1 R) 和食欲素-2 受体(orexin-2 …

[PDF][PDF] Synthesis of Azulene-Based Compounds for Targeting Orexin Receptors

TO Leino - 2018 - helda.helsinki.fi
Orexin peptides, orexin-A and orexin-B, and orexin receptor 1 and orexin receptor 2 form the
orexin signaling system. The most studied part of the orexin system is its key role in sleep …

Combination therapy

KDG Pfleger, E McCall, J Williams - US Patent 10,058,555, 2018 - Google Patents
2004-093527 2010-540527 A 96/40258 WO 00/25134 WO 04/022786 WO 05/050182 WO
05/031309 2006/029349 2008/000421 2008/055313 2008/060621 WO 08/055313 …